 the
concerns of cumulative radiation, iodinated contrast exposure, and late endograft collapse, the optimal strategy for
long-term follow-up of these patients post-TEVAR remains in evolution. Opinions varied widely within the
committee as to the frequency and types of imaging that
should be utilized. In the absence of any abnormalities on
imaging (ie, stable endograft position, no endoleak) in the
first 12 to 36 months,